Autolus Therapeutics (AUTL) Return on Sales Growth (5y) (2022 - 2025)

Autolus Therapeutics (AUTL) Return on Sales Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Autolus Therapeutics 404.53 Mn 103.82 Mn -1.04 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 102.00
Sep 30, 2025 81.00
Jun 30, 2025 107.00
Mar 31, 2025 81.00
Jun 30, 2024 2.00
Mar 31, 2024 9.00
Dec 31, 2023 -65.00
Sep 30, 2023 33.00
Jun 30, 2023 7.00
Dec 31, 2022 25.00